|
1
|
Pharoah PD, Dunning AM, Ponder BA and
Easton DF: Association studies for finding cancer-susceptibility
genetic variants. Nat Rev Cancer. 4:850–860. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kiyohara C and Yoshimasu K: Genetic
polymorphisms in the nucleotide excision repair pathway and lung
cancer risk: a meta-analysis. Int J Med Sci. 4:59–71. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiang CC, Tsai YY, Bau DT, Cheng YW,
Tseng SH, Wang RF and Tsai FJ: Pterygium and genetic polymorphisms
of the DNA repair enzymes XRCC1, XPA, and XPD. Mol Vis. 16:698–704.
2010.PubMed/NCBI
|
|
4
|
Takenaka T, Yano T, Kiyohara C, Miura N,
Kouso H, Ohba T, Kometani T, Shoji F, Yoshino I and Maehara Y:
Effects of excision repair cross-complementation group 1 (ERCC1)
single nucleotide polymorphisms on the prognosis of non-small cell
lung cancer patients. Lung Cancer. 67:101–107. 2010. View Article : Google Scholar
|
|
5
|
Fukunaga AK, Marsh S, Murry DJ, Hurley TD
and McLeod HL: Identification and analysis of single-nucleotide
polymorphisms in the gemcitabine pharmacologic pathway.
Pharmacogenomics J. 4:307–314. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lunn RM, Helzlsouer KJ, Parshad R, Umbach
DM, Harris EL, Sanford KK and Bell DA: XPD polymorphisms: effects
on DNA repair proficiency. Carcinogenesis. 21:551–555. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hemminki K, Xu G, Angelini S, Snellman E,
Jansen CT, Lambert B and Hou SM: XPD exon 10 and 23 polymorphisms
and DNA repair in human skin in situ. Carcinogenesis. 22:1185–1188.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spitz MR, Wu X, Wang Y, Wang LE, Shete S,
Amos CI, Guo Z, Lei L, Mohrenweiser H and Wei Q: Modulation of
nucleotide excision capacity by XPD polymorphisms in lung cancer
patients. Cancer Res. 61:1354–1357. 2001.PubMed/NCBI
|
|
9
|
Jelonek K, Gdowicz-Klosok A, Pietrowska M,
Borkowska M, Korfanty J, Rzeszowska-Wolny J and Widlak P:
Association between single-nucleotide polymorphisms of selected
genes involved in the response to DNA damage and risk of colon,
head and neck, and breast cancers in a Polish population. J Appl
Genet. 51:343–352. 2010. View Article : Google Scholar
|
|
10
|
Tomescu D, Kavanagh G, Ha T, Campbell H
and Melton DW: Nucleotide excision repair gene XPD polymorphisms
and genetic predisposition to melanoma. Carcinogenesis. 22:403–408.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Laliberté J and Momparler RL: Human
cytidine deaminase: purification of enzyme, cloning, and expression
of its complementary DNA. Cancer Res. 54:5401–5407. 1994.PubMed/NCBI
|
|
12
|
Yue L, Saikawa Y, Ota K, Tanaka M,
Nishimura R, Uehara T, Maeba H, Ito T, Sasaki T and Koizumi S: A
functionnal single-nucleotide polymorphism in the human cytidine
deaminase gene contributing to ara-C sensitivity. Pharmacogenetics.
13:29–38. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rosell R, Taron M, Ariza A, Barnadas A,
Mate JL, Reguart N, Margel M, Felip E, Méndez P and García-Campelo
R: Molecular predictors of response to chemotherapy in lung cancer.
Semin Oncol. 31:20–27. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maring JG, Wachters FM, Slijfer M, Maurer
JM, Boezen HM, Uges DR, de Vries EG and Groen HJ: Pharmacokinetics
of gemcitabine in non-small-cell lung cancer patients: impact of
the 79A>C cytidine deaminase polymorphism. Eur J Clin Pharmacol.
66:611–617. 2010. View Article : Google Scholar
|
|
15
|
Yue LJ, Chen XW, Li CR, Li CG, Shi HS and
Zhang M: Single-nucleotide polymorphisms of the cytidine deaminase
gene in childhood with acute leukemia and normal Chinese children.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 24:699–702. 2007.PubMed/NCBI
|
